How to tackle the ‘toxic’ financial costs of cancer A cancer survivor, a GP and a researcher share their views on how to mitigate and prepare for the financial pain the disease can cause.
New software integration a ‘tremendous advance’ MedicalDirector has become the second clinical software provider to link with the National Cancer Screening Register.
‘It can be quite insidious’: Identifying lung cancer New resources have been designed to help GPs notice the signs of lung cancer, which can be notoriously difficult to diagnose in general practice.
Can self-collection help overcome cervical screening barriers? Associate Professor Julia Brotherton says it has the potential, but must first become widely accessible and well understood in the Australian setting.
Cancer Australia releases multilingual FAQs on COVID-19 vaccines The organisation has compiled documents in 10 different languages to inform patients from diverse backgrounds about COVID-19 vaccines.
New study seeks to ‘notably’ improve ovarian cancer survival rates The world-first research will use artificial intelligence to predict risk factors of the fatal cancer over the next 15 years.
Lack of awareness key barrier to breast cancer chemoprophylaxis It can reduce the risk of breast cancer by one-third to one-half, yet new research finds 35% of GPs are unaware of chemoprophylaxis.
Media fails to cover harms of early diagnostic testing: study Researchers fear a lack of risk–benefit analysis may be contributing to overdiagnosis.
COVID vaccines and cancer patients Cancer Australia has developed a set of frequently asked questions designed to help address patient concerns.
Calls to reduce breast cancer screening age spark overdiagnosis fears New research suggests screening from age 40 has better outcomes for reducing breast cancer mortality. But is that really the case?